Avadim Health.

Avadim Health, a developer of nonprescription topical treatments based here, postponed its $75 million initial public offering. In January, the company filed with regulators to offer 5 million shares with a target price range of $14 to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT